MARINA BIOTECH INC (MRNA)

0.68
OTC Markets
Prev Close 0.81
Day Low/High 0.68 / 0.79
52 Wk Low/High 0.68 / 5.00
Exchange OTC Markets
Shares Outstanding 10.85B
Market Cap 8.79M
Div & Yield N.A. (N.A)

Latest News

Marina Biotech And Mirna Therapeutics Amend License Agreement For The Development Of MicroRNA-based Therapeutics

Marina Biotech And Mirna Therapeutics Amend License Agreement For The Development Of MicroRNA-based Therapeutics

Marina Biotech, Inc. (OTC Pink: MRNA), a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics, Inc.

5 Biggest Drug-Stock Losers of 2011

5 Biggest Drug-Stock Losers of 2011

Reading this list of stinkers incites a little Schadenfreude as one company fell 99.6%.

Encorium Group, MDRNA: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

7 Firms Developing RNAi Drugs

7 Firms Developing RNAi Drugs

Biotech investors are paying close attention to RNAi. Here are seven drug and biotech companies focused on developing RNAi drugs.

MRNA, Pacific Ethanol: Midday Volume Plays

Several stocks trading near $5 were moving on above-average volume during Monday's session.

Sirius XM, Tellabs: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.

MDRNA Draws Bullish Options Trade

MDRNA, a drug developer, reported positive results for an experimental cancer treatment last week and at least one investor is positioning for a rally by summer.

Ballard Power, Enterra: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.

MDRNA, Affymetrix: Early Volume Plays

MDRNA, Affymetrix: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.

MDRNA Shares Rise On Debt Repayment

MDRNA Shares Rise On Debt Repayment

MDRNA shares rise following full repayment of $5.5 million in debt to GE Capital

Texas Instruments, Ceradyne Are Big Movers

Texas Instruments, Ceradyne, Quiksilver, Marvell Technology among big market movers Tuesday

Movers Roundup: MDRNA, Callaway Golf

Movers roundup: MDRNA shares hit year high, Callaway Golf slides on cut dividend, share issue

MDRNA Rockets Following Generic Miacalcin Approval

MDRNA Rockets Following Generic Miacalcin Approval

MDRNA says FDA approved osteoporosis drug, which has been launched; stock rockets to year high

Feuerstein's Biotech-Stock Mailbag: Acadia

Feuerstein's Biotech-Stock Mailbag: Acadia

Sizing up Acadia; a Nastech by any other name; and can Nuvelo stage a comeback?